Drugs / Xihuang Capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02399033 | Jun 2014 → Jul 2019 | hepatocellular carcinoma | Shuqun Cheng | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xihuang Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02399033 ↗ |
| Known as | Wangbang Pharmaceutical Xihuang Capsules | “Wangbang Pharmaceutical Xihuang Capsules” NCT02399033 ↗ |